Biote (BTMD) Non-Current Deffered Revenue (2020 - 2026)

Biote's Non-Current Deffered Revenue history runs 7 years deep, the most recent figure standing at $922000.0 for Q1 2026.

• In Q1 2026, Non-Current Deffered Revenue fell 36.41% year-over-year to $922000.0; the TTM figure through Mar 2026 stood at $922000.0 (down 36.41% YoY), while the FY2025 annual figure was $1.1 million, down 29.36% from the prior year.
• Non-Current Deffered Revenue was $922000.0 for Q1 2026 at Biote, down from $1.1 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $11.1 million in Q1 2022 to a low of $853000.0 in Q2 2022.
• Historically, Non-Current Deffered Revenue has averaged $1.8 million across 5 years, with a median of $1.2 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Non-Current Deffered Revenue slumped 92.32% in 2022, then jumped 44.16% in 2024.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $926000.0 in 2022, then soared by 42.76% to $1.3 million in 2023, then increased by 17.47% to $1.6 million in 2024, then dropped by 29.36% to $1.1 million in 2025, then dropped by 15.95% to $922000.0 in 2026.
• The last three Non-Current Deffered Revenue figures came in at $922000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.